Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)

HKG:1349 Statistics

Total Valuation

HKG:1349 has a market cap or net worth of HKD 7.60 billion. The enterprise value is 6.38 billion.

Market Cap	7.60B
Enterprise Value	6.38B

Important Dates

The next confirmed earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1349 has 1.04 billion shares outstanding.

Current Share Class	326.00M
Shares Outstanding	1.04B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+226.65%
Owned by Insiders (%)	24.44%
Owned by Institutions (%)	2.90%
Float	416.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.96
PB Ratio	3.03
P/TBV Ratio	3.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-36.40
EV / Sales	8.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6.90% and return on invested capital (ROIC) is -13.44%.

Return on Equity (ROE)	-6.90%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-13.44%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.91%
Revenue Per Employee	826,828
Profits Per Employee	-189,816
Employee Count	899
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:1349 has paid 1.77 million in taxes.

Income Tax	1.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.92% in the last 52 weeks. The beta is 0.12, so HKG:1349's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+18.92%
50-Day Moving Average	3.08
200-Day Moving Average	3.35
Relative Strength Index (RSI)	47.38
Average Volume (20 Days)	2,012,070

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1349 had revenue of HKD 763.16 million and -175.20 million in losses. Loss per share was -0.17.

Revenue	763.16M
Gross Profit	763.16M
Operating Income	-172.93M
Pretax Income	-173.43M
Net Income	-175.20M
EBITDA	-113.41M
EBIT	-172.93M
Loss Per Share	-0.17

Balance Sheet

The company has 1.24 billion in cash and 17.75 million in debt, with a net cash position of 1.23 billion or 1.18 per share.

Cash & Cash Equivalents	1.24B
Total Debt	17.75M
Net Cash	1.23B
Net Cash Per Share	1.18
Equity (Book Value)	2.51B
Book Value Per Share	2.42
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -22.66% and -22.96%.

Gross Margin	100.00%
Operating Margin	-22.66%
Pretax Margin	-22.73%
Profit Margin	-22.96%
EBITDA Margin	-14.86%
EBIT Margin	-22.66%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 2.21%.

Dividend Per Share	0.07
Dividend Yield	2.21%
Dividend Growth (YoY)	-28.93%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.25%
Earnings Yield	-2.30%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1